المؤلفون: Jørgensen N; Department of Clinical Biochemistry, Centre for Immune Regulation and Reproductive Immunology (CIRRI), Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Hviid TVF; Department of Clinical Biochemistry, Centre for Immune Regulation and Reproductive Immunology (CIRRI), Zealand University Hospital, Roskilde, Denmark. tvh@regionsjaelland.dk.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. tvh@regionsjaelland.dk., Nielsen LB; Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Sønderstrup IMH; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark., Eriksen JO; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark., Ejlertsen B; Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Jensen MB; Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.

المصدر: British journal of cancer [Br J Cancer] 2021 Nov; Vol. 125 (10), pp. 1388-1398. Date of Electronic Publication: 2021 Aug 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*mortality , Lymphocytes, Tumor-Infiltrating/*immunology, Adult ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; CD4 Antigens/metabolism ; CD8 Antigens/metabolism ; Denmark ; Disease-Free Survival ; Female ; Forkhead Transcription Factors/metabolism ; Humans ; Middle Aged ; Mutation ; Prognosis ; Young Adult

المؤلفون: Olafsdottir EJ; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland., Borg A; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Jensen MB; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Johansson ALV; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Barkardottir RB; Laboratory of Cell Biology, Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.; Faculty of Medicine, BMC, Laeknagardur, University of Iceland, Reykjavik, Iceland., Johannsson OT; Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland., Ejlertsen B; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Sønderstrup IMH; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Radium Hospital, Oslo University Hospital, Oslo, Norway., Lænkholm AV; Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark., Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Olafsdottir GH; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland., Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Jonasson JG; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland., Sigurdsson S; Cancer Research Laboratory, BMC, School of Health Sciences, University of Iceland, Reykjavik, Iceland., Loman N; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Nilsson MP; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Narod SA; Womens' College Research Institute, University of Toronto, Toronto, ON, Canada., Tryggvadottir L; Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland. laufeyt@krabb.is.; Faculty of Medicine, BMC, Laeknagardur, University of Iceland, Reykjavik, Iceland. laufeyt@krabb.is.

المصدر: British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1608-1615. Date of Electronic Publication: 2020 Sep 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: BRCA2 Protein/*genetics , Breast Neoplasms/*genetics , Breast Neoplasms/*metabolism , Receptors, Estrogen/*metabolism, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/mortality ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Middle Aged ; Mutation ; Scandinavian and Nordic Countries

المؤلفون: Sønderstrup IMH; a Department of Surgical Pathology Region Zealand , Zealand University Hospital , Slagelse , Denmark., Jensen MB; b Danish Breast Cancer Cooperative Group , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark., Ejlertsen B; b Danish Breast Cancer Cooperative Group , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark.; c Department of Oncology , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark., Eriksen JO; a Department of Surgical Pathology Region Zealand , Zealand University Hospital , Slagelse , Denmark., Gerdes AM; d Department of Clinical Genetics , Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark., Kruse TA; e Department of Clinical Genetics , Odense University Hospital , Odense , Denmark., Larsen MJ; e Department of Clinical Genetics , Odense University Hospital , Odense , Denmark., Thomassen M; e Department of Clinical Genetics , Odense University Hospital , Odense , Denmark., Laenkholm AV; a Department of Surgical Pathology Region Zealand , Zealand University Hospital , Slagelse , Denmark.

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Mar; Vol. 58 (3), pp. 363-370. Date of Electronic Publication: 2019 Jan 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*mortality , Breast Neoplasms/*pathology , Lymphocytes, Tumor-Infiltrating/*pathology, Adolescent ; Adult ; Aged ; Breast Neoplasms/genetics ; Cohort Studies ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Mutation ; Prognosis

المؤلفون: Sønderstrup IMH; Department of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse 4200, Denmark. Electronic address: idms@regionsjaelland.dk., Jensen MR; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark., Ejlertsen B; Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark., Eriksen JO; Department of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse 4200, Denmark., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen 2100, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense 5000, Denmark., Larsen MJ; Department of Clinical Genetics, Odense University Hospital, Odense 5000, Denmark., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense 5000, Denmark., Lænkholm AV; Department of Surgical Pathology Region Zealand, Zealand University Hospital, Slagelse 4200, Denmark.

المصدر: Human pathology [Hum Pathol] 2019 Feb; Vol. 84, pp. 192-201. Date of Electronic Publication: 2018 Oct 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: W B Saunders Country of Publication: United States NLM ID: 9421547 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8392 (Electronic) Linking ISSN: 00468177 NLM ISO Abbreviation: Hum Pathol Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*pathology, Adult ; Aged ; Breast Neoplasms/classification ; Breast Neoplasms/mortality ; Disease-Free Survival ; Female ; Germ-Line Mutation ; Humans ; Middle Aged ; Young Adult